Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Recovery of carotid body function after neuromuscular block and sugammadex
2020-000057-27Phase 4Active
- Sponsor
- Leiden University Medical Center
- Start
- Feb 2020
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4 trial of Sugammadex in postoperative ventilatory control disorder (PVCD) (2 arms), sponsored by Leiden University Medical Center. Primary endpoints: Time to full recovery of hypoxic ventilatory response without sugammadex, Time to full recovery of hypoxic ventilatory response with sugammadex and 1 more. Started Feb 2020; status: active.
02
Drugs
Sugammadex
03
Conditions
postoperative ventilatory control disorder (PVCD)
Beyond the preview
Go deeper on 2020-000057-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-000057-27.